Canon U.S.A., Inc., a leader in digital imaging solutions, today announced the appointment of Akiko Tanaka as president and CEO of Canon U.S. Life Sciences, Inc. (CLS), a wholly owned subsidiary of Canon U.S.A., Inc. Ms. Tanaka, previously the vice president and COO of CLS, has also been appointed to the CLS Board of Directors. In this position, Ms. Tanaka will oversee the management of business initiatives relating to the development of diagnostic solutions. Dr. Ivor Knight, senior vice president and CTO, will report directly to Ms. Tanaka to support these initiatives.

Ms. Tanaka also has recently been appointed as the president and CEO of the newly established Canon BioMedical, Inc. (CBMI) which focuses on the development, manufacturing, and marketing operations relating to life science and molecular diagnostics businesses. This new company will look for long-term future growth opportunities in previously untapped markets for Canon such as life science, healthcare, and medical analysis through the use of existing and emerging Canon technology, as well as strategic partnerships.

“I am confident under the leadership of Ms. Tanaka, Canon will succeed in its mission to develop innovative technologies and solutions that assist in improving human health and in advancing science,” said Joe Adachi, chairman and CEO, Canon U.S.A., Inc.

“I am honored to take on this new role and to help align the overall biomedical strategy in the Canon Americas,” said Tanaka. “Both CLS and CBMI will work together to research, develop and bring new technologies to markets all over the world.”

Ms. Tanaka has spent 29 years working for Canon and joined Canon U.S.A. in April 2012. She began her career at Canon Inc. in 1986 as a system engineer doing software development in R&D and later joined a Strategic Alliance that handled all of Canon Inc.'s OEM business.

For additional information about Canon U.S. Life Sciences, Inc. visit www.culs.canon.com.

About Canon U.S. Life Sciences, Inc.

Founded in 2002 and located in Rockville, Maryland, Canon U.S. Life Sciences, Inc., is a subsidiary of Canon U.S.A., Inc., dedicated to identifying and developing diagnostic solutions to help address unmet medical needs and improving human health.

About Canon U.S.A., Inc.

Canon U.S.A., Inc., is a leading provider of consumer, business-to-business, and industrial digital imaging solutions to the United States and to Latin America and the Caribbean (excluding Mexico) markets. With approximately $31 billion in global revenue, its parent company, Canon Inc. (NYSE:CAJ), ranked third overall in U.S. patents granted in 2014† and is one of Fortune Magazine's World’s Most Admired Companies in 2015. In 2014, Canon U.S.A. received the PCMag.com Readers’ Choice Award for Service and Reliability in the digital camera and printer categories for the 11th consecutive year. Canon U.S.A. is committed to the highest level of customer satisfaction and loyalty, providing 100 percent U.S.-based consumer service and support for all of the products it distributes. Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. In 2014, the Canon Americas Headquarters secured LEED® Gold certification, a recognition for the design, construction, operations and maintenance of high-performance green buildings. To keep apprised of the latest news from Canon U.S.A., sign up for the Company's RSS news feed by visiting www.usa.canon.com/rss and follow us on Twitter @CanonUSA.

† Based on weekly patent counts issued by United States Patent and Trademark Office.

All referenced product names, and other marks, are trademarks of their respective owners.

Editorial:Canon U.S.A., Inc.Emily Moran, 631-330-2403emmoran@cusa.canon.comorFor sales information/customer support:1-800-OK-CANONorCanon U.S.A. website:http://www.usa.canon.com

Canon (NYSE:CAJ)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Canon Charts.
Canon (NYSE:CAJ)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Canon Charts.